RYRHX
Price
$69.57
Change
-$0.34 (-0.49%)
Updated
Jul 31 closing price
Net Assets
15.66M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RYRHX vs VSCIX

RYRHX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
RYRHX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYRHX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. RYRHX (15.7M). VSCIX pays higher dividends than RYRHX: VSCIX (1.23) vs RYRHX (0.55). RYRHX was incepted earlier than VSCIX: RYRHX (20 years) vs VSCIX (29 years). RYRHX (1.68) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. RYRHX (9.00). RYRHX has a lower initial minimum investment than VSCIX: RYRHX (2500) vs VSCIX (5000000). RYRHX annual gain was more profitable for investors over the last year : 31.88 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. RYRHX (14.90).
RYRHXVSCIXRYRHX / VSCIX
Total Expense Ratio1.630.035,433%
Annual Report Gross Expense Ratio1.680.035,600%
Fund Existence20 years29 years-
Gain YTD17.69614.591121%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.7M189B0%
Annual Yield % from dividends0.551.2345%
Returns for 1 year31.8822.58141%
Returns for 3 years45.7243.44105%
Returns for 5 years14.9035.1342%
Returns for 10 years96.51156.0762%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C